Award
Delivery Order #SPE2DR26FCFD3
DMS Pharmaceutical Group Awarded Delivery Order for STELARA Syringes
Buyer
Defense Logistics Agency
Award Amount
$16,584.13
Ceiling
$16,584.13
Awarded
March 03, 2026
Period of Performance
Mar 03, 2026 – Mar 24, 2026
Identifier
SPE2DR26FCFD3
NAICS
424210
This award is a delivery order contract issued to DMS Pharmaceutical Group Inc. for the procurement of STELARA 90 MG/ML syringes, a critical pharmaceutical product. DMS Pharmaceutical Group, known for its expertise in pharmaceutical supply and services, is providing essential medical products under this order. The contract supports an existing indefinite delivery vehicle (IDV) previously awarded to the company, which focuses on long-term pharmaceutical services for government healthcare needs. This delivery order ensures continued access to vital medications within the public health sector, supporting effective medical treatment and patient care. The contract work involves the timely delivery of these specialty syringes in Park Ridge, IL, over a short, defined performance period of approximately three weeks. The award follows a broader competitive framework established by the parent IDV, reinforcing a reliable supply chain for healthcare products. This short-term delivery order aligns with the agency’s ongoing pharmaceutical acquisition strategy, ensuring consistent availability of necessary medical supplies.
Description
4571080699!STELARA 90 MG/ML SYRINGEML